Stem Cell Therapy Contract Manufacturing Market, 2030 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Dec 3, 2019--
The “Stem Cell Therapy Contract Manufacturing Market, 2019-2030” report has been added to ResearchAndMarkets.com’s offering.
The Stem Cell Therapies Contract Manufacturing Market, 2019 - 2030 report features an extensive study on contract service providers engaged in the development and manufacturing of stem cell therapies. The study features in-depth analyses, highlighting the capabilities of various stem cell therapy CMOs.
Advances in the fields of cell biology and regenerative medicine have led to the development of a variety of stem cell-based therapies for many cardiovascular, oncological, metabolic and musculoskeletal disorders. Driven by the revenues generated from stem cell therapies, the regenerative medicine market is anticipated to generate revenues worth USD 100 billion by 2030. With a promising pipeline of over 200 stem cell therapy candidates, it has become essential for developers to scale up the production of such therapeutic interventions. Given that stem cell therapy manufacturing requires highly regulated, state-of-the-art technologies, it is difficult for stakeholders to establish in-house expertise for large-scale manufacturing of stem cell therapies.
As a result, stem cell therapy developers have begun outsourcing their manufacturing operations to contract manufacturing organizations (CMOs). Specifically, small and mid-sized players in this sector tend to outsource a substantial proportion of clinical and commercial-scale manufacturing processes to contract service providers. In addition, even big pharma players, with established in-house capabilities, are gradually entering into long-term business relationships with CMOs in order to optimize resource utilization and manage costs.
According to a recent Nice Insight CDMO survey, about 55% of 700 respondents claimed to have collaborated with a contract service provider for clinical and commercial-scale product development requirements. Considering the prevalent trends, we believe that the stem cell therapy manufacturing market is poised to grow at a steady pace, driven by a robust pipeline of therapy candidates and technological advances aimed at mitigating challenges posed by conventional methods of production. Amidst tough competition, the availability of cutting-edge tools and technologies has emerged as a differentiating factor and is likely to grant a competitive advantage to certain CMOs over other players in the industry.
One of the key objectives of the report was to estimate the future size of the market. Based on parameters, such as increase in number of clinical studies, target patient population, anticipated adoption of stem cell therapies and expected variation in manufacturing costs, we have provided an informed estimate of the likely evolution of the market in the mid to long term, for the period 2019-2030.
Amongst other elements, the report includes:
In order to provide a detailed future outlook, our projections have been segmented on the basis of:
Key Topics Covered:
2. Executive Summary
4. Market Overview
5. Regulatory Landscape
6. Stem Cell Therapy Contract Manufacturers In North America
7. Stem Cell Therapy Contract Manufacturers In Europe And Asia-Pacific
8. Partnerships And Collaboration
9. Contract Manufacturing Opportunity Assessment
10. Capacity Analysis
11. Demand Analysis
12. Market Forecast
13. Key Performance Indicators
14. Concluding Remark
15. Executive Insights
16. Appendix 1: Tabulated Data
17. Appendix 2: List Of Companies And Organizations
For more information about this report visit https://www.researchandmarkets.com/r/ib3bbo
View source version on businesswire.com:https://www.businesswire.com/news/home/20191203005513/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH STEM CELLS
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 12/03/2019 06:03 AM/DISC: 12/03/2019 06:03 AM